Professor Susan Branford

Adjunct Professor Centre for Cancer Biology

City West Campus (HB8-26)
tel +61 8 830 27730

email Susan.Branford@unisa.edu.au

Research Degree Supervisor

Research

Research focus

Clinical Sciences
Cardiovascular Medicine and Haematology
Oncology and Carcinogenesis
Paediatrics and Reproductive Medicine
Biochemistry and Cell Biology

Research

Outputs

Research since 2008 is shown below. To see earlier years visit ORCID

Open access indicates that an output is open access.

Journal Articles

Year	Output
2020	Branford, S 2020, 'Why is it critical to achieve a deep molecular response in chronic myeloid leukemia?', Haematologica: The Hematology Journal, vol. 105, no. 12, pp. 2730-2737. Open access 5
2020	Pagani, IS, Dang, P, Saunders, VA, Braley, J, Thieleke, A, Branford, S, Hughes, TP & Ross, DM 2020, 'Clinical utility of genomic DNA Q-PCR for the monitoring of a patient with atypical e19a2 BCR-ABL1 transcripts in chronic myeloid leukemia', Leukemia and Lymphoma, vol. 61, no. 10, pp. 2527-2529. 1 1
2020	Thomson, DW, Shahrin, NH, Wang, PP, Wadham, C, Shanmuganathan, N, Scott, HS, Dinger, ME, Hughes, TP, Schreiber, AW & Branford, S 2020, 'Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia', Leukemia, online, pp. 1-13. Open access 3 3 1
2019	Branford, S, Kim, DDH, Apperley, JF, Eide, CA, Mustjoki, S, Ong, ST, Nteliopoulos, G, Ernst, T, Chuah, C, Gambacorti-Passerini, C, Mauro, MJ, Druker, BJ, Kim, D-W, Mahon, F-X, Cortes, J, Radich, JP, Hochhaus, A & Hughes, TP and 1 consortia 2019, 'Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia', Leukemia, vol. 33, no. 8, pp. 1835-1850. Open access 20 24 2
2019	Lasica, M, Willcox, A, Burbury, K, Ross, DM, Branford, S, Butler, J, Filshie, R, Januszewicz, H, Joske, D, Mills, A, Simpson, D, Tam, C, Taylor, K, Watson, AM, Wolf, M & Grigg, A 2019, 'The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia', Leukemia and Lymphoma, vol. 60, no. 7, pp. 1796-1802. Open access 4 5
2019	Pagani, IS, Dang, P, Saunders, VA, Grose, R, Shanmuganathan, N, Kok, CH, Carne, L, Rwodzi, Z, Watts, S, McLean, J, Braley, J, Altamura, H, Yeung, DT, Branford, S, Yong, AS, White, DL, Hughes, TP & Ross, DM 2019, 'Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission', Leukemia, online, pp. 1-10. Open access 10 9 3
2019	Ross, DM, Pagani, IS, Irani, YD, Clarson, J, Leclercq, T, Dang, P, McLean, J, Saunders, VA, Carne, L, Reynolds, J, Ritchie, DS, White, DL, Branford, S, Hughes, TP & Yong, AS 2019, 'Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia', British Journal of Haematology, vol. 186, no. 3, pp. e56-e60. Open access 4 4 3
2019	Shanmuganathan, N & Branford, S 2019, 'The hidden pathogenesis of CML: is BCR-ABL1 the first event?', Current Hematologic Malignancy Reports, vol. 14, no. 6, pp. 501-506. Open access 2 1
2019	Shanmuganathan, N, Braley, JA, Yong, AS, Hiwase, DK, Yeung, DT, Ross, DM, Hughes, TP & Branford, S 2019, 'Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission', Blood, vol. 134, no. 1, pp. 85-89. Open access 7 8 7
2019	Shanmuganathan, N, Branford, S, Hughes, TP & Hiwase, D 2019, 'Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI', Blood Advances, vol. 3, no. 3, pp. 370-374. Open access 1 1 5
2019	Sharplin, K, Altamura, H, Taylor, K, Wellwood, J, Taylor, D & Branford, S 2019, 'Chronic myeloid leukaemia: the dangers of not knowing your BCR-ABL1 transcript', Leukemia Research, vol. 87, article no. 106231, pp. 1-3. Open access 2 3 1
2019	Singhal, D, Wee, LYA, Kutyna, MM, Chhetri, R, Schreiber, AW, Feng, J, Branford, S, D'Andrea, RJ & Hiwase, D and 18 other authors 2019, 'The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution', Leukemia, vol. 33, no.12, pp. 2842-2853. 9 8 3
2018	Branford, S, Wang, P, Yeung, DT, Thomson, D, Wadham, C, Shahrin, NH, Marum, JE, Nataren, N, Parker, WT, Shanmuganathan, N, Donaldson, Z, Altamura, H, Georgievski, J, Brown, A, Hahn, C, White, DL, Scott, HS, Schreiber, AW & Hughes, TP and 18 other authors 2018, 'Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease', Blood, vol. 132, no. 9, pp. 948-961. Open access 41 46 8
2018	Eadie, LN, Saunders, VA, Branford, S, White, DL & Hughes, TP 2018, 'The new allosteric inhibitor asciminib is susceptible to resistance mediated by ABCB1 and ABCG2 overexpression in vitro', Oncotarget, vol. 9, no. 17, pp. 13423-13437. Open access 12 2
2018	Pagani, IS, Dang, P, Kommers, IO, Goyne, JM, Nicola, M, Saunders, VA, Braley, J, White, DL, Yeung, DT, Branford, S, Hughes, TP & Ross, DM 2018, 'BCR-ABL1 genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemia', Haematologica: The Hematology Journal, vol. 103, no. 12, pp. 2026-2032. Open access 13 9 5
2018	Ross, DM, Pagani, IS, Shanmuganathan, N, Kok, CH, White, DL, Branford, S & Hughes, TP and 11 other authors and 1 constourium 2018, 'Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells', Leukemia, vol. 32, no. 12, pp. 2572-2579. 21 18 4
2017	Casolari, D, Nguyen, T, Butcher, C, Iarossi, D, Hahn, C, Bray, S, Neufing, P, Parker, W, Feng, J, Maung, K, Wee, A, Vidovic, L, Kok, C, Bardy, P, Branford, S, Lewis, I, Lane, S, Scott, H, Ross, D & D'Andrea, R 2017, 'A novel, somatic, transforming mutation in the extracellular domain of epidermal growth factor receptor identified in myeloproliferative neoplasm', Scientific Reports, vol. 7, article no. 2467, pp. 1-9. Open access 1 1 3
2017	Hochhaus, A, Larson, RA, Guilhot, F, Radich, JP, Branford, S, Hughes, TP, Baccarani, M, Deininger, MW, Cervantes, F, Fujihara, S, Ortmann, CE, Menssen, HD, Kantarjian, H, O'Brien, SG & Druker, BJ 2017, 'Long-term outcomes of imatinib treatment for chronic myeloid leukemia', New England Journal of Medicine, vol. 376, pp. 917-927. Open access 397 386 922
2017	Hughes, T, Leber, B, Cervantes, F, Spector, N, Pasquini, R, Clementino, N, Schwarer, A, Dorlhiac-Llacer, P, Mahon, F, Rea, D, Guerci-Bresler, A, Kamel-Reid, S, Bendit, I, Acharya, S, Glynos, T, Dalal, D, Branford, S & Lipton, J 2017, 'Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: Final ENESTcmr randomized trial results', Leukemia, vol. 31, no. 11, pp. 2529-2531. Open access 24 25 2
2017	Ma, L, Boucher, JI, Paulsen, J, Matuszewski, S, Eide, CA, Ou, J, Eickelberg, G, Press, RD, Zhu, LJ, Druker, BJ, Branford, S, Wolfe, SA, Jensen, JD, Schiffer, CA, Green, MR & Bolon, DN 2017, 'CRISPR-Cas9-mediated saturated mutagenesis screen predicts clinical drug resistance with improved accuracy', Proceedings of the National Academy of Sciences of USA, vol. 114, no. 44, pp. 11751-11756. Open access 18 16 7
2017	Marum, JE, Yeung, DT, Purins, L, Reynolds, J, Parker, WT, Stangl, D, Wang, PP, Price, DJ, Tuke, J, Schreiber, AW, Scott, HS, Hughes, TP & Branford, S 2017, 'ASXL1 and BIM germ line variants predict response and identify CML patients with the greatest risk of imatinib failure', Blood Advances, vol. 1, no. 18, pp. 1369-1381. Open access 7 7 7
2017	Wylie, AA, Schoepfer, J, Jahnke, W, Cowan-Jacob, SW, Branford, S & Sellers, WR and 22 other authors 2017, 'The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1', Nature, vol. 543, no. 7647, pp. 733-737. Open access 178 168 60
2016	Branford, S 2016, 'Molecular monitoring in chronic myeloid leukemia - How low can you go?', Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, vol. 2016, no. 1, pp. 156-163. Open access 11 8
2016	Branford, S 2016, 'Monitoring and defining early response: where to draw the line?', Best Practice and Research: Clinical Haematology, vol. 29, no. 3 pp. 284-294. 4 4
2016	Cross, N, White, H, Ernst, T, Welden, L & Branford, S and 51 other authors 2016, 'Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale', Leukemia, vol. 30, no. 9, pp. 1844-1852. Open access 29 24 10
2016	Deininger, MW, Hodgson, JG, Shah, NP, Cortes, JE & Branford, S and 16 other authors 2016, 'Compound mutations in BCR-ABL1 are not major drivers of primary or secondary resistance to ponatinib in CP-CML patients', Blood, vol. 127, no. 6, pp. 703-712. Open access 63 62 13
2016	Parker, WT, Yeung, DT, Yeoman, AL, Altamura, HK, Jamison, BA, Field, CR, Hodgson, JG, Lustgarten, S, Rivera, VM, Hughes, TP & Branford, S 2016, 'The impact of multiple low-level BCR-ABL1 mutations on response to ponatinib', Blood, vol. 127, no. 15, pp. 1870-1880. Open access 40 38 6
2016	Ross, D, Altamura, H, Hahn, C, Nicola, M, Yeoman, A, Holloway, M, Geoghegan, J, Feng, J, Schreiber, A, Branford, S, Moore, S & Scott, H 2016, 'Delayed diagnosis leading to accelerated-phase chronic eosinophilic leukemia due to a cytogenetically cryptic, imatinib-responsive TNIP1-PDFGRB fusion gene', Leukemia, vol. 30, no. 6, pp. 1402-1405. 4 4
2016	Yoshida, C, Nakamae, H, Fletcher, L, Koga, D, Sogabe, T, Matsumura, I, Kanakura, Y, Branford, S & Naoe, T 2016, 'Validation of a rapid one-step high sensitivity real-time quantitative PCR system for detecting major BCR-ABL1 mRNA on an International Scale', SpringerPlus, vol. 5, no. 569, pp. 1-7. Open access 2 2
2015	Yeung, DT, Osborn, MP, White, DL, Branford, S & Hughes, TP and 18 other authors and 1 consortium 2015, 'TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets', Blood, vol. 125, no. 6, pp. 915-923. Open access 65 59 2
2015	Yeung, DT, Tang, C, Vidovic, L, White, DL, Branford, S, Hughes, TP & Yong, AS 2015, 'KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy', Blood, vol. 126, no. 25, pp. 2720-2723. Open access 10 7 11
2014	Parker, WT, Phillis, SR, Yeung, DT, Hughes, TP, Scott, HS & Branford, S 2014, 'Many BCR-ABL1 compound mutations reported in chronic myeloid leukemia patients may actually be artifacts due to PCR-mediated recombination', Blood, vol. 124, no. 1, pp. 153-155. Open access 20 20 1

Conferences

Year	Output
2016	Wang, P, Parker, WT, Branford, S & Schreiber, AW 2016, 'BAM-matcher: a tool for rapid NGS sample matching', 15th European Conference on Computational Biology (ECCB), Oxford University Press, vol. 32, no. 17, pp. 2699-2701. Open access 12 10 17

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
ARIAD Pharmaceuticals	UNITED STATES
Austin Hospital	AUSTRALIA
Brabois Hospital	FRANCE
Catholic University of Korea	KOREA, REPUBLIC OF (SOUTH)
Ecole Polytechnique Federale de Lausanne	ITALY
Federal University of Parana	BRAZIL
Federal University of Rio de Janeiro	BRAZIL
Flinders University	AUSTRALIA
Fred Hutchinson Cancer Research Center	AUSTRALIA
Greenslopes Private Hospital	AUSTRALIA
Hammersmith Hospital	UNITED KINGDOM
Hopital Saint-Louis	FRANCE
Howard Hughes Medical Institute	UNITED STATES
Kinki University	JAPAN
Liverpool Hospital Elizabeth	AUSTRALIA
Mater Medical Centre	AUSTRALIA
Mater Pathology	AUSTRALIA
McMaster University	CANADA
Memorial Sloan-Kettering Cancer Center	UNITED STATES
Mito Medical Centre	JAPAN
Monash University	AUSTRALIA
Nagoya Medical Centre	JAPAN
New Jersey City University	UNITED STATES
Newcastle University, United Kingdom	UNITED KINGDOM
NHS Foundation Trust	UNITED KINGDOM
Novartis Healthcare	UNITED STATES
Novartis Pharma AG Switzerland	SWITZERLAND
Novartis Pharmaceuticals	UNITED STATES
Oregon Health and Science University	UNITED STATES
Osaka City University	JAPAN
Osaka University	JAPAN
Otsuka Pharmaceutical	JAPAN
Peter MacCallum Cancer Centre	AUSTRALIA
Princess Margaret Hospital for Children	AUSTRALIA
Queen Elizabeth Hospital	AUSTRALIA
Queensland Institute of Medical Research	AUSTRALIA
Royal Adelaide Hospital	AUSTRALIA
Royal Brisbane and Women's Hospital	AUSTRALIA
Royal North Shore Hospital	AUSTRALIA
SA Pathology	AUSTRALIA
Singapore General Hospital	SINGAPORE
Sir Charles Gardiner Hospital	AUSTRALIA
South Australian Health and Medical Research Institute (SAHMRI)	AUSTRALIA
St Vincents Hospital	UNITED STATES
The Alfred Hospital	AUSTRALIA
Toronto General Hospital	CANADA
Universidade de Sao Paulo - USP	BRAZIL
Universidade Fed de Minas Gerais	BRAZIL
Universidade Federal Do Estado Do Rio De Janeiro	BRAZIL
Universitätsklinikum Jena	GERMANY
Universite Victor Segalen	FRANCE
University Hospital, Bordeaux	FRANCE
University of Adelaide	AUSTRALIA
University of Barcelona	SPAIN
University of Bologna	ITALY
University of Bordeaux	FRANCE
University of California San Francisco	UNITED STATES
University of Chicago	UNITED STATES
University of Helsinki	FINLAND
University of Jena	GERMANY
University of Massachusetts Medical School	UNITED STATES
University of Milano Bicocca	ITALY
University of New South Wales	AUSTRALIA
University of Poitiers	FRANCE
University of Queensland	AUSTRALIA
University of Sao Paulo	BRAZIL
University of South Australia	AUSTRALIA
University of Southampton	UNITED KINGDOM
University of Texas	UNITED STATES
University of Texas MD Anderson Cancer Centre	UNITED STATES
University of Toronto	CANADA
University of Utah	UNITED STATES
VU University Medical Center	NETHERLANDS

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Defining genomic mechanisms associated with tyrosine kinase inhibitor response, drug resistance, prognosis and progression in chronic myeloid leukaemia	Current
Interactive visualization tools for cancer genomics	Current

more less

Professor Susan Branford

About me

About me

Centre for Cancer Biology

About me

Professional Associations

Experience

Qualifications

Research

Research focus

Projects

Outputs

Journal Articles

Conferences

External engagement & recognition

Collaborations

Collaborations

Teaching & student supervision

Courses and programs

Research degree supervision

Gallery